Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

计划入组 390 人 · 首次发布于 2013 年 11 月 25 日

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

计划入组 48 人 · 首次发布于 2009 年 9 月 25 日

A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

计划入组 116 人 · 首次发布于 2011 年 7 月 29 日

mRNA vaccine (intramuscular/ pandemic influenza H5 virus infection)

ios-H5

Assembly Biosciences

United States

AbbVie CDR (CAD Hedged)

United States

Enanta Pharmaceuticals

United States

European Medicines Agency Recommends Approval for Two Boehringer Ingelheim Avian Flu Vaccines

Clinical Trial Evaluating Safety and Immunogenicity of Bird Flu Vaccines

Trump Administration Cancels $590 Million Moderna Bird Flu Vaccine Contract Amid mRNA Technology Review